<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>APPROVED</status><version>v2</version><patient-age>73</patient-age><report-id>IT-SANOFI-AVENTIS-2013SA001426</report-id><gender>male</gender><reactions><reaction>tendonitis</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>CARVEDILOL</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>TRIATEC</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>LASIX</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>LANSOPRAZOLE</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>LEVOFLOXACIN</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>METFORMIN</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>NITRO-DUR</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>CARDIOASPIRIN</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>BRONCOVALEAS</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>CLENIL</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>CLEXANE</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>IDROPLURIVIT</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>TORVAST</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>10019277</indication><indication>10020772</indication><indication>10057097</indication><indication>10035664</indication><indication>10067585</indication><indication>10053468</indication></indications><patient-age>73</patient-age><outcomes><outcome>Required Inpatient Hospitalization</outcome></outcomes><country>Italy</country><geo/></meta><original><ichicsr lang="en" xmlns="">
<ichicsrmessageheader>
<messagetype>ichicsr</messagetype>
<messageformatversion>2.1</messageformatversion>
<messageformatrelease>1.0</messageformatrelease>
<messagenumb>78949</messagenumb>
<messagesenderidentifier>SAAVPROD</messagesenderidentifier>
<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
<messagedateformat>204</messagedateformat>
<messagedate>20130125151452</messagedate>
</ichicsrmessageheader>
<safetyreport>
<safetyreportversion>1</safetyreportversion>
<safetyreportid>IT-SANOFI-AVENTIS-2013SA001426</safetyreportid>
<primarysourcecountry>IT</primarysourcecountry>
<occurcountry>IT</occurcountry>
<transmissiondateformat>102</transmissiondateformat>
<transmissiondate>2013-01-25</transmissiondate>
<reporttype>1</reporttype>
<serious code="1">Yes</serious>
<seriousnessdeath>2</seriousnessdeath>
<seriousnesslifethreatening>2</seriousnesslifethreatening>
<seriousnesshospitalization>1</seriousnesshospitalization>
<seriousnessdisabling>2</seriousnessdisabling>
<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
<receivedateformat>102</receivedateformat>
<receivedate>2013-01-08</receivedate>
<receiptdateformat>102</receiptdateformat>
<receiptdate>2013-01-08</receiptdate>
<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
<companynumb>IT-SANOFI-AVENTIS-2013SA001426</companynumb>
<duplicate>1</duplicate>
<reportduplicate>
<duplicatesource>ITA-AIFA</duplicatesource>
<duplicatenumb>187756</duplicatenumb>
</reportduplicate>
<reportduplicate>
<duplicatesource>PCP_DAIICHI SANKYO_JPN</duplicatesource>
<duplicatenumb>IT2013/00030</duplicatenumb>
</reportduplicate>
<primarysource>
<reporterorganization>Italian Medicines Agency</reporterorganization>
<reportercountry>IT</reportercountry>
<qualification code="3">Other Health Professional</qualification>
</primarysource>
<primarysource>
<reportercountry>IT</reportercountry>
<qualification code="1">Physician</qualification>
</primarysource>
<primarysource>
<reportercountry>IT</reportercountry>
<qualification code="2">Pharmacist</qualification>
</primarysource>
<sender>
<sendertype>1</sendertype>
<senderorganization>sanofi-aventis</senderorganization>
<senderdepartment>US Affiliate Pharmacovigilance</senderdepartment>
<sendergivename>Barbara</sendergivename>
<senderfamilyname>Rullo</senderfamilyname>
<senderstreetaddress>55A-435 55 Corporate Drive</senderstreetaddress>
<sendercity>Bridgewater</sendercity>
<senderstate>NJ</senderstate>
<senderpostcode>08807</senderpostcode>
<sendercountrycode>US</sendercountrycode>
<sendertel>9089816698</sendertel>
<sendertelcountrycode>1</sendertelcountrycode>
<senderfax>9089877894</senderfax>
<senderfaxcountrycode>1</senderfaxcountrycode>
<senderemailaddress>Barbara.Rullo@sanofi-aventis.com</senderemailaddress>
</sender>
<receiver>
<receivertype>2</receivertype>
<receiverorganization>ZZFDA</receiverorganization>
<receiverdepartment>Center for Drug Evaluation and Research</receiverdepartment>
<receiverstreetaddress>5600 Fishers lane</receiverstreetaddress>
<receivercity>Rockville</receivercity>
<receiverstate>MD</receiverstate>
<receiverpostcode>20857</receiverpostcode>
<receivercountrycode>US</receivercountrycode>
<receivertel>3018273237</receivertel>
<receivertelcountrycode>1</receivertelcountrycode>
<receiveremailaddress>aersesub@cder.fda.gov</receiveremailaddress>
</receiver>
<patient>
<patientinitial>CP</patientinitial>
<patientbirthdateformat>102</patientbirthdateformat>
<patientbirthdate>19390722</patientbirthdate>
<patientonsetage>73</patientonsetage>
<patientonsetageunit>801</patientonsetageunit>
<patientagegroup>6</patientagegroup>
<patientsex code="1">Male</patientsex>
<resultstestsprocedures>Date: unknown
osteo-tendon echography was performed.</resultstestsprocedures>
<medicalhistoryepisode>
<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
<patientepisodename>10055217</patientepisodename>
<patientmedicalcontinue>1</patientmedicalcontinue>
</medicalhistoryepisode>
<medicalhistoryepisode>
<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
<patientepisodename>10066551</patientepisodename>
<patientmedicalcontinue>1</patientmedicalcontinue>
</medicalhistoryepisode>
<medicalhistoryepisode>
<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
<patientepisodename>10038683</patientepisodename>
<patientmedicalcontinue>1</patientmedicalcontinue>
</medicalhistoryepisode>
<reaction>
<primarysourcereaction>tendonitis</primarysourcereaction>
<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
<reactionmeddrallt>10043255</reactionmeddrallt>
<termhighlighted>4</termhighlighted>
<reactionstartdateformat>102</reactionstartdateformat>
<reactionstartdate>20130103</reactionstartdate>
<reactionfirsttime>8</reactionfirsttime>
<reactionfirsttimeunit>804</reactionfirsttimeunit>
<reactionoutcome code="6">unknown</reactionoutcome>
</reaction>
<drug>
<drugcharacterization code="1">suspsect</drugcharacterization>
<medicinalproduct>CARVEDILOL</medicinalproduct>
<drugbatchnumb>UNKNOWN</drugbatchnumb>
<drugstructuredosagenumb>18</drugstructuredosagenumb>
<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
<drugseparatedosagenumb>1</drugseparatedosagenumb>
<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
<drugadministrationroute code="048">Oral</drugadministrationroute>
<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
<drugindication>10019277</drugindication>
<drugstartdateformat>102</drugstartdateformat>
<drugstartdate>2012-12-26</drugstartdate>
<drugstartperiod>8</drugstartperiod>
<drugstartperiodunit>804</drugstartperiodunit>
<drugenddateformat>102</drugenddateformat>
<drugenddate>2013-01-08</drugenddate>
<drugtreatmentduration>14</drugtreatmentduration>
<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
<actiondrug code="5">Unknown</actiondrug>
<drugadditional code="Form:Unknown"/>
<activesubstance>
<activesubstancename>CARVEDILOL</activesubstancename>
</activesubstance>
</drug>
<drug>
<drugcharacterization code="1">suspsect</drugcharacterization>
<medicinalproduct>TRIATEC</medicinalproduct>
<drugbatchnumb>UNKNOWN</drugbatchnumb>
<drugstructuredosagenumb>2</drugstructuredosagenumb>
<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
<drugseparatedosagenumb>1</drugseparatedosagenumb>
<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
<drugdosageform normalized="tablet">TABLET</drugdosageform>
<drugadministrationroute code="048">Oral</drugadministrationroute>
<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
<drugindication>10020772</drugindication>
<drugstartdateformat>102</drugstartdateformat>
<drugstartdate>2012-12-26</drugstartdate>
<drugstartperiod>8</drugstartperiod>
<drugstartperiodunit>804</drugstartperiodunit>
<drugenddateformat>102</drugenddateformat>
<drugenddate>2013-01-08</drugenddate>
<drugtreatmentduration>14</drugtreatmentduration>
<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
<actiondrug code="5">Unknown</actiondrug>
<activesubstance>
<activesubstancename>RAMIPRIL</activesubstancename>
</activesubstance>
</drug>
<drug>
<drugcharacterization code="1">suspsect</drugcharacterization>
<medicinalproduct>LASIX</medicinalproduct>
<drugbatchnumb>UNKNOWN</drugbatchnumb>
<drugauthorizationnumb>NDA 16-273</drugauthorizationnumb>
<drugstructuredosagenumb>25</drugstructuredosagenumb>
<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
<drugseparatedosagenumb>1</drugseparatedosagenumb>
<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
<drugdosageform normalized="tablet">TABLET</drugdosageform>
<drugadministrationroute code="048">Oral</drugadministrationroute>
<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
<drugindication>10057097</drugindication>
<drugstartdateformat>102</drugstartdateformat>
<drugstartdate>2012-12-26</drugstartdate>
<drugstartperiod>8</drugstartperiod>
<drugstartperiodunit>804</drugstartperiodunit>
<drugenddateformat>102</drugenddateformat>
<drugenddate>2013-01-08</drugenddate>
<drugtreatmentduration>14</drugtreatmentduration>
<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
<actiondrug code="5">Unknown</actiondrug>
<activesubstance>
<activesubstancename>FUROSEMIDE</activesubstancename>
</activesubstance>
</drug>
<drug>
<drugcharacterization code="1">suspsect</drugcharacterization>
<medicinalproduct>LANSOPRAZOLE</medicinalproduct>
<drugbatchnumb>UNKNOWN</drugbatchnumb>
<drugstructuredosagenumb>30</drugstructuredosagenumb>
<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
<drugseparatedosagenumb>1</drugseparatedosagenumb>
<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
<drugadministrationroute code="048">Oral</drugadministrationroute>
<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
<drugindication>10057097</drugindication>
<drugstartdateformat>102</drugstartdateformat>
<drugstartdate>2012-12-26</drugstartdate>
<drugstartperiod>8</drugstartperiod>
<drugstartperiodunit>804</drugstartperiodunit>
<drugenddateformat>102</drugenddateformat>
<drugenddate>2013-01-08</drugenddate>
<drugtreatmentduration>14</drugtreatmentduration>
<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
<actiondrug code="5">Unknown</actiondrug>
<drugadditional code="Form:Unknown"/>
<activesubstance>
<activesubstancename>LANSOPRAZOLE</activesubstancename>
</activesubstance>
</drug>
<drug>
<drugcharacterization code="1">suspsect</drugcharacterization>
<medicinalproduct>LEVOFLOXACIN</medicinalproduct>
<drugbatchnumb>UNKNOWN</drugbatchnumb>
<drugstructuredosagenumb>500</drugstructuredosagenumb>
<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
<drugseparatedosagenumb>1</drugseparatedosagenumb>
<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
<drugadministrationroute code="042">Intravenous (not otherwise specified)</drugadministrationroute>
<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
<drugindication>10035664</drugindication>
<drugstartdateformat>102</drugstartdateformat>
<drugstartdate>2012-12-26</drugstartdate>
<drugstartperiod>8</drugstartperiod>
<drugstartperiodunit>804</drugstartperiodunit>
<drugenddateformat>102</drugenddateformat>
<drugenddate>2013-01-01</drugenddate>
<drugtreatmentduration>7</drugtreatmentduration>
<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
<actiondrug code="1">Drug Withdrawn</actiondrug>
<drugadditional code="Form:Unknown"/>
<activesubstance>
<activesubstancename>LEVOFLOXACIN</activesubstancename>
</activesubstance>
</drug>
<drug>
<drugcharacterization code="1">suspsect</drugcharacterization>
<medicinalproduct>METFORMIN</medicinalproduct>
<drugbatchnumb>UNKNOWN</drugbatchnumb>
<drugstructuredosagenumb>100</drugstructuredosagenumb>
<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
<drugseparatedosagenumb>1</drugseparatedosagenumb>
<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
<drugadministrationroute code="048">Oral</drugadministrationroute>
<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
<drugindication>10067585</drugindication>
<drugstartdateformat>102</drugstartdateformat>
<drugstartdate>2012-12-26</drugstartdate>
<drugstartperiod>8</drugstartperiod>
<drugstartperiodunit>804</drugstartperiodunit>
<drugenddateformat>102</drugenddateformat>
<drugenddate>2012-12-29</drugenddate>
<drugtreatmentduration>4</drugtreatmentduration>
<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
<actiondrug code="5">Unknown</actiondrug>
<drugadditional code="Form:Unknown"/>
<activesubstance>
<activesubstancename>METFORMIN HYDROCHLORIDE</activesubstancename>
</activesubstance>
</drug>
<drug>
<drugcharacterization code="1">suspsect</drugcharacterization>
<medicinalproduct>NITRO-DUR</medicinalproduct>
<drugbatchnumb>UNKNOWN</drugbatchnumb>
<drugstructuredosagenumb>10</drugstructuredosagenumb>
<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
<drugseparatedosagenumb>1</drugseparatedosagenumb>
<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
<drugdosagetext>strength: 10 mg/die</drugdosagetext>
<drugdosageform normalized="transdermal patch">TRANSDERMAL PATCH</drugdosageform>
<drugadministrationroute code="062">Transdermal</drugadministrationroute>
<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
<drugindication>10057097</drugindication>
<drugstartdateformat>102</drugstartdateformat>
<drugstartdate>2012-12-26</drugstartdate>
<drugenddateformat>102</drugenddateformat>
<drugenddate>2013-01-08</drugenddate>
<actiondrug code="5">Unknown</actiondrug>
<activesubstance>
<activesubstancename>GLYCERYL TRINITRATE</activesubstancename>
</activesubstance>
</drug>
<drug>
<drugcharacterization code="1">suspsect</drugcharacterization>
<medicinalproduct>CARDIOASPIRIN</medicinalproduct>
<drugbatchnumb>UNKNOWN</drugbatchnumb>
<drugstructuredosagenumb>100</drugstructuredosagenumb>
<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
<drugseparatedosagenumb>1</drugseparatedosagenumb>
<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
<drugdosageform normalized="gastro-resistant tablet">GASTRO-RESISTANT TABLET</drugdosageform>
<drugadministrationroute code="048">Oral</drugadministrationroute>
<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
<drugindication>10053468</drugindication>
<drugstartdateformat>102</drugstartdateformat>
<drugstartdate>2012-12-26</drugstartdate>
<drugstartperiod>8</drugstartperiod>
<drugstartperiodunit>804</drugstartperiodunit>
<drugenddateformat>102</drugenddateformat>
<drugenddate>2012-12-29</drugenddate>
<drugtreatmentduration>4</drugtreatmentduration>
<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
<actiondrug code="5">Unknown</actiondrug>
<activesubstance>
<activesubstancename>ACETYLSALICYLIC ACID</activesubstancename>
</activesubstance>
</drug>
<drug>
<drugcharacterization code="1">suspsect</drugcharacterization>
<medicinalproduct>BRONCOVALEAS</medicinalproduct>
<drugbatchnumb>UNKNOWN</drugbatchnumb>
<drugdosagetext>form: solution for nebulization
strength: 0.5 %</drugdosagetext>
<drugadministrationroute code="065">Unknown</drugadministrationroute>
<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
<drugindication>10035664</drugindication>
<drugstartdateformat>102</drugstartdateformat>
<drugstartdate>2013-01-01</drugstartdate>
<drugstartperiod>8</drugstartperiod>
<drugstartperiodunit>804</drugstartperiodunit>
<drugenddateformat>102</drugenddateformat>
<drugenddate>2013-01-07</drugenddate>
<drugtreatmentduration>13</drugtreatmentduration>
<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
<actiondrug code="5">Unknown</actiondrug>
<drugadditional code="Form:Unknown"/>
<activesubstance>
<activesubstancename>SALBUTAMOL</activesubstancename>
</activesubstance>
</drug>
<drug>
<drugcharacterization code="1">suspsect</drugcharacterization>
<medicinalproduct>CLENIL</medicinalproduct>
<drugbatchnumb>UNKNOWN</drugbatchnumb>
<drugstructuredosagenumb>100</drugstructuredosagenumb>
<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
<drugseparatedosagenumb>1</drugseparatedosagenumb>
<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
<drugdosagetext>route: intranasal</drugdosagetext>
<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
<drugindication>10035664</drugindication>
<drugstartdateformat>102</drugstartdateformat>
<drugstartdate>2012-12-26</drugstartdate>
<drugstartperiod>8</drugstartperiod>
<drugstartperiodunit>804</drugstartperiodunit>
<drugenddateformat>102</drugenddateformat>
<drugenddate>2013-01-01</drugenddate>
<drugtreatmentduration>7</drugtreatmentduration>
<drugtreatmentdurationunit code="804">Day</drugtreatmentdurationunit>
<actiondrug code="5">Unknown</actiondrug>
<drugadditional code="Form:Unknown"/>
<activesubstance>
<activesubstancename>BECLOMETASONE DIPROPIONATE</activesubstancename>
</activesubstance>
</drug>
<drug>
<drugcharacterization code="2">concomitant</drugcharacterization>
<medicinalproduct>CLEXANE</medicinalproduct>
<drugstartdateformat>102</drugstartdateformat>
<drugstartdate>2013-01-02</drugstartdate>
<drugenddateformat>102</drugenddateformat>
<drugenddate>2013-01-04</drugenddate>
<activesubstance>
<activesubstancename>ENOXAPARIN SODIUM</activesubstancename>
</activesubstance>
</drug>
<drug>
<drugcharacterization code="2">concomitant</drugcharacterization>
<medicinalproduct>IDROPLURIVIT</medicinalproduct>
<drugstartdateformat>102</drugstartdateformat>
<drugstartdate>2013-01-02</drugstartdate>
<drugenddateformat>102</drugenddateformat>
<drugenddate>2013-01-04</drugenddate>
<activesubstance>
<activesubstancename>VITAMINS NOS</activesubstancename>
</activesubstance>
</drug>
<drug>
<drugcharacterization code="2">concomitant</drugcharacterization>
<medicinalproduct>TORVAST</medicinalproduct>
<activesubstance>
<activesubstancename>ATORVASTATIN CALCIUM</activesubstancename>
</activesubstance>
</drug>
<summary>
<narrativeincludeclinical>This serious unsolicited case from Italy (local reference no.: 2013-IT 000056) was received on 08-Jan 2013 from Health Authorities of Italy (<Semaphore x="2081918" class="Race" value="Italian" score="1.00" ID="C43857">Italian </Semaphore>Medicines Agency; regulatory no.: 187756) via a <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>and <Semaphore x="1805433" class="Procedure" value="Concern About Finances" score="1.00" ID="C104604">concerns </Semaphore>a 73-years old male patient who experienced <Semaphore x="780931" class="Medicine" value="Levofloxacin" score="1.00" ID="285592">levofloxacin </Semaphore>induced bilateral <Semaphore x="1412261" class="AnatomicStructure" value="Achilles Tendon" score="1.00" ID="C32043">Achilles <Semaphore x="2605309" class="AnatomicStructure" value="Tendon" score="1.00" ID="C13045">tendon </Semaphore></Semaphore><Semaphore x="2605291" class="Disease or Finding" value="Tendonitis" score="1.00" ID="C97141">tendonitis </Semaphore>whilst receiving <Semaphore x="780931" class="Medicine" value="Levofloxacin" score="1.00" ID="285592">levofloxacin </Semaphore>for <Semaphore x="2411042" class="Disease or Finding" value="Pneumonia" score="1.00" ID="C3333">pneumonia</Semaphore>.On 26-Dec 2012, the patient commenced <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">therapy </Semaphore>with intravenous <Semaphore x="780931" class="Medicine" value="Levofloxacin" score="1.00" ID="285592">levofloxacin </Semaphore>at a dose of 500 mg daily (form, lot/batch number and expiration date unknown). After 8 days of <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>on 03-Jan 2013, he experienced <Semaphore x="780931" class="Medicine" value="Levofloxacin" score="1.00" ID="285592">levofloxacin </Semaphore>induced bilateral <Semaphore x="1412261" class="AnatomicStructure" value="Achilles Tendon" score="1.00" ID="C32043">Achilles <Semaphore x="2605309" class="AnatomicStructure" value="Tendon" score="1.00" ID="C13045">tendon </Semaphore></Semaphore><Semaphore x="2605291" class="Disease or Finding" value="Tendonitis" score="1.00" ID="C97141">tendonitis</Semaphore>. <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">Therapy </Semaphore>with <Semaphore x="780931" class="Medicine" value="Levofloxacin" score="1.00" ID="285592">levofloxacin </Semaphore>was discontinued on 04-Jan 2013. The patient was <Semaphore x="2149581" class="Procedure" value="Maintenance Therapy" score="1.00" ID="C15688">maintained </Semaphore>at rest and an osteo <Semaphore x="2605201" class="AnatomicStructure" value="Tendon Sheath" score="1.00" ID="C96299">tendon </Semaphore><Semaphore x="3294274" class="MedDRA LLT" value="Ultrasound scan" score="1.00" ID="10045434">echography </Semaphore>was performed. No information regarding the corrective <Semaphore x="1568617" class="Disease or Finding" value="Behavior-Related Disorder" score="1.00" ID="C35470">conduct </Semaphore>was provided.<Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">Outcome </Semaphore>for the event was unknown.The patient슿s concomitant medications included salbutamol (Broncovaleas) and beclometasone dipropionate (Clenil) both for <Semaphore x="2411042" class="Disease or Finding" value="Pneumonia" score="1.00" ID="C3333">pneumonia </Semaphore>, <Semaphore x="1119676" class="Medicine" value="Ramipril" score="0.98" ID="258414">ramipril </Semaphore>(Triatec) for <Semaphore x="1904394" class="Disease or Finding" value="Essential Hypertension" score="1.00" ID="C3478">essential hypertension</Semaphore>, <Semaphore x="608230" class="Medicine" value="Furosemide" score="0.74" ID="269027">furosemide </Semaphore>(<Semaphore x="771590" class="Medicine" value="Lasix" score="0.93" ID="241395">Lasix</Semaphore>) for <Semaphore x="3195768" class="MedDRA LLT" value="Polyuria" score="1.00" ID="10036142"><Semaphore x="1861041" class="Procedure" value="Diuretic Measurement" score="1.00" ID="C75384">diuretic </Semaphore>effect</Semaphore>, <Semaphore x="770601" class="Medicine" value="lansoprazole" score="0.98" ID="239887">lansoprazole </Semaphore>for <Semaphore x="1965163" class="Disease or Finding" value="Gastroesophageal Reflux Disease" score="1.00" ID="C26781">gastroesophageal reflux disease</Semaphore>, <Semaphore x="309609" class="Medicine" value="carvedilol" score="0.98" ID="241573">carvedilol </Semaphore>for <Semaphore x="1725522" class="Disease or Finding" value="Cardiomegaly" score="1.00" ID="C61453">cardiomegaly</Semaphore>, <Semaphore x="857793" class="Medicine" value="metFORMIN hydrochloride" score="0.98" ID="249555">metformin hydrochloride </Semaphore>(<Semaphore x="857859" class="Medicine" value="metFORMIN" score="0.74" ID="279450">Metformin</Semaphore>) for <Semaphore x="1845561" class="Disease or Finding" value="Diabetes Mellitus" score="1.00" ID="C2985"><Semaphore x="1845561" class="Disease or Finding" value="Diabetes Mellitus" score="1.00" ID="C2985">diabetes mellitus type 2</Semaphore>, </Semaphore>glyceryl trinitrate (<Semaphore x="929097" class="Medicine" value="Nitro-Dur" score="0.98" ID="241287">Nitro DUR</Semaphore>) for <Semaphore x="2419940" class="Disease or Finding" value="Pressure Sore" score="1.00" ID="C50706">decubitus </Semaphore><Semaphore x="1525451" class="Disease or Finding" value="Angina" score="1.00" ID="C51221">angina</Semaphore>, acetylsalicylic <Semaphore x="2147465" class="Procedure" value="Lysergide Measurement" score="1.00" ID="C75354">acid </Semaphore>(Cardioaspirin), <Semaphore x="530331" class="Medicine" value="Enoxaparin sodium" score="0.74" ID="249134">enoxaparin <Semaphore x="2536895" class="Procedure" value="Sodium Measurement" score="1.00" ID="C64809">sodium </Semaphore></Semaphore>(Clexane) and idroplurivit. The patient슿s concurrent conditions included dilatative <Semaphore x="3050986" class="MedDRA LLT" value="Ischaemic cardiomyopathy" score="1.00" ID="10048858">ischemic <Semaphore x="1725577" class="Disease or Finding" value="Cardiomyopathy" score="1.00" ID="C34830">cardiomyopathy</Semaphore></Semaphore>, <Semaphore x="1845561" class="Disease or Finding" value="Diabetes Mellitus" score="1.00" ID="C2985">diabetes mellitus</Semaphore>, <Semaphore x="1553233" class="Disease or Finding" value="Atrial Fibrillation" score="1.00" ID="C50466">chronic <Semaphore x="2766382" class="MedDRA LLT" value="Atrial fibrillation" score="1.00" ID="10003658">atrial fibrillation </Semaphore></Semaphore>and restrictive respiratory deficit. No past <Semaphore x="1670730" class="Procedure" value="CAM Pharmacological or Biological Treatment" score="1.00" ID="C15906">drugs </Semaphore>were reported.A further evaluation was planned for 09-Jan 2013.Additional information was received on 09-Jan 2013 from local health authority.Route of <Semaphore x="780931" class="Medicine" value="Levofloxacin" score="1.00" ID="285592">levofloxacin </Semaphore>was changed from <Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral </Semaphore>to intravenous. Suspect <Semaphore x="1670730" class="Procedure" value="CAM Pharmacological or Biological Treatment" score="1.00" ID="C15906">drugs </Semaphore>salbutamol (Broncovaleas), beclometasone dipropionate (Clenil), <Semaphore x="1119676" class="Medicine" value="Ramipril" score="0.98" ID="258414">ramipril </Semaphore>(Triatec), <Semaphore x="608230" class="Medicine" value="Furosemide" score="0.74" ID="269027">furosemide </Semaphore>(<Semaphore x="771590" class="Medicine" value="Lasix" score="0.93" ID="241395">Lasix</Semaphore>), <Semaphore x="770601" class="Medicine" value="lansoprazole" score="0.98" ID="239887">lansoprazole</Semaphore>, <Semaphore x="309609" class="Medicine" value="carvedilol" score="0.98" ID="241573">carvedilol</Semaphore>, <Semaphore x="857793" class="Medicine" value="metFORMIN hydrochloride" score="0.98" ID="249555">metformin hydrochloride </Semaphore>(<Semaphore x="857859" class="Medicine" value="metFORMIN" score="0.74" ID="279450">Metformin</Semaphore>), glyceryl trinitrate (<Semaphore x="929097" class="Medicine" value="Nitro-Dur" score="0.98" ID="241287">Nitro DUR</Semaphore>) and acetylsalicylic <Semaphore x="2147465" class="Procedure" value="Lysergide Measurement" score="1.00" ID="C75354">acid </Semaphore>(Cardioaspirin) was considered concomitant medication in this follow up. Concomitant medications <Semaphore x="530331" class="Medicine" value="Enoxaparin sodium" score="0.74" ID="249134">enoxaparin <Semaphore x="2536895" class="Procedure" value="Sodium Measurement" score="1.00" ID="C64809">sodium </Semaphore></Semaphore>(Clexane) and idroplurivit were added.Additional information was reported by GlaxoSmithKline to our license partner Daiichi Sankyo on 21-Jan 2013 as case number ID (B085854A).In follow up information previously reported concomitant medications (<Semaphore x="189558" class="Medicine" value="Beclomethasone Dipropionate" score="0.93" ID="227553">beclomethasone dipropionate </Semaphore>(Clenil), salbutamol sulphate (Broncovaleas), <Semaphore x="166901" class="Medicine" value="Aspirin" score="0.93" ID="212518">aspirin </Semaphore>(Cardioaspirin), frusemide (<Semaphore x="771590" class="Medicine" value="Lasix" score="0.93" ID="241395">Lasix</Semaphore>), <Semaphore x="1119676" class="Medicine" value="Ramipril" score="0.98" ID="258414">ramipril </Semaphore>(Triatec), nitroglycerine (<Semaphore x="929097" class="Medicine" value="Nitro-Dur" score="0.98" ID="241287">Nitrodur</Semaphore>), <Semaphore x="857793" class="Medicine" value="metFORMIN hydrochloride" score="0.98" ID="249555">metformin hydrochloride </Semaphore>(Metformina), <Semaphore x="770601" class="Medicine" value="lansoprazole" score="0.98" ID="239887">lansoprazole </Semaphore>and <Semaphore x="309609" class="Medicine" value="carvedilol" score="0.98" ID="241573">carvedilol</Semaphore>) were captured as co suspects.This case was reported by a <Semaphore x="2394141" class="Occupation" value="Pharmacist" score="1.00" ID="C51840">pharmacist </Semaphore>via the <Semaphore x="2081918" class="Race" value="Italian" score="1.00" ID="C43857">Italian </Semaphore>regulatory authority and described the occurrence of suspected bilateral achilleus <Semaphore x="2605291" class="Disease or Finding" value="Tendonitis" score="1.00" ID="C97141">tendonitis </Semaphore>in a 73-year old male patient who received <Semaphore x="780931" class="Medicine" value="Levofloxacin" score="1.00" ID="285592">levofloxacin </Semaphore>(Levoxacin) for <Semaphore x="2411042" class="Disease or Finding" value="Pneumonia" score="1.00" ID="C3333">pneumonia</Semaphore>.Concurrent medical conditions included <Semaphore x="1553174" class="Disease or Finding" value="Atrial Fibrillation by ECG Finding" score="1.00" ID="C111092">atrial fibrillation</Semaphore><Semaphore x="2081060" class="Disease or Finding" value="Ischemic Heart Disease" score="1.00" ID="C50625">, <Semaphore x="2081060" class="Disease or Finding" value="Ischemic Heart Disease" score="1.00" ID="C50625">ischemic heart disease</Semaphore><Semaphore x="1845561" class="Disease or Finding" value="Diabetes Mellitus" score="1.00" ID="C2985">, </Semaphore></Semaphore>
    <Semaphore x="2659498" class="Disease or Finding" value="Type 2 Diabetes Mellitus" score="1.00" ID="C26747">
     <Semaphore x="2038093" class="Disease or Finding" value="Hypertension" score="1.00" ID="C3117">hypertension</Semaphore><Semaphore x="1845561" class="Disease or Finding" value="Diabetes Mellitus" score="1.00" ID="C2985">, <Semaphore x="1845561" class="Disease or Finding" value="Diabetes Mellitus" score="1.00" ID="C2985">diabetes mellitus type 2 </Semaphore></Semaphore></Semaphore>and respiratory disease. Co suspect medication included <Semaphore x="189558" class="Medicine" value="Beclomethasone Dipropionate" score="0.93" ID="227553">beclomethasone dipropionate </Semaphore>(Clenil), salbutamol sulphate (Broncovaleas), <Semaphore x="166901" class="Medicine" value="Aspirin" score="0.93" ID="212518">aspirin </Semaphore>(Cardioaspirin), frusemide (<Semaphore x="771590" class="Medicine" value="Lasix" score="0.93" ID="241395">Lasix</Semaphore>), <Semaphore x="1119676" class="Medicine" value="Ramipril" score="0.98" ID="258414">ramipril </Semaphore>(Triatec), nitroglycerine (<Semaphore x="929097" class="Medicine" value="Nitro-Dur" score="0.98" ID="241287">Nitrodur</Semaphore>), <Semaphore x="857793" class="Medicine" value="metFORMIN hydrochloride" score="0.98" ID="249555">metformin hydrochloride </Semaphore>(Metformina), <Semaphore x="770601" class="Medicine" value="lansoprazole" score="0.98" ID="239887">lansoprazole </Semaphore>and <Semaphore x="309609" class="Medicine" value="carvedilol" score="0.98" ID="241573">carvedilol</Semaphore>.On 26 December 2012, the patient started <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>with <Semaphore x="780931" class="Medicine" value="Levofloxacin" score="1.00" ID="285592">levofloxacin </Semaphore>(<Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral</Semaphore>) at a <Semaphore x="1824009" class="AnatomicStructure" value="Cuneate Nucleus" score="1.00" ID="C52716">total daily dose </Semaphore>of 500 mg, <Semaphore x="189558" class="Medicine" value="Beclomethasone Dipropionate" score="0.93" ID="227553">beclomethasone dipropionate </Semaphore>(intranasal) at a <Semaphore x="1824009" class="AnatomicStructure" value="Cuneate Nucleus" score="1.00" ID="C52716">total daily dose </Semaphore>of 100mg, <Semaphore x="166901" class="Medicine" value="Aspirin" score="0.93" ID="212518">aspirin </Semaphore>(<Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral</Semaphore>) at a <Semaphore x="1824009" class="AnatomicStructure" value="Cuneate Nucleus" score="1.00" ID="C52716">total daily dose </Semaphore>of 100mg, frusemide (<Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral</Semaphore>) at a <Semaphore x="1824009" class="AnatomicStructure" value="Cuneate Nucleus" score="1.00" ID="C52716">total daily dose </Semaphore>of 25mg, <Semaphore x="1119676" class="Medicine" value="Ramipril" score="0.98" ID="258414">ramipril </Semaphore>(<Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral</Semaphore>) at a <Semaphore x="1824009" class="AnatomicStructure" value="Cuneate Nucleus" score="1.00" ID="C52716">total daily dose </Semaphore>of 2mg, nitroglycerine (transdermal) at a <Semaphore x="1824009" class="AnatomicStructure" value="Cuneate Nucleus" score="1.00" ID="C52716">total daily dose </Semaphore>of 10mg, <Semaphore x="857793" class="Medicine" value="metFORMIN hydrochloride" score="0.98" ID="249555">metformin hydrochloride </Semaphore>(<Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral</Semaphore>) at a <Semaphore x="1824009" class="AnatomicStructure" value="Cuneate Nucleus" score="1.00" ID="C52716">total daily dose </Semaphore>of 100mg, <Semaphore x="770601" class="Medicine" value="lansoprazole" score="0.98" ID="239887">lansoprazole </Semaphore>(<Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral</Semaphore>) at a <Semaphore x="1824009" class="AnatomicStructure" value="Cuneate Nucleus" score="1.00" ID="C52716">total daily dose </Semaphore>of 30mg and <Semaphore x="309609" class="Medicine" value="carvedilol" score="0.98" ID="241573">carvedilol </Semaphore>(<Semaphore x="2336704" class="AnatomicStructure" value="Oral Cavity" score="1.00" ID="C12421">oral</Semaphore>) at a <Semaphore x="1824009" class="AnatomicStructure" value="Cuneate Nucleus" score="1.00" ID="C52716">total daily dose </Semaphore>of 18mg. On 1 January 2013, the patient started <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>with salbutamol sulphate at an unspecified dose. Approximately 8 days after starting <Semaphore x="780931" class="Medicine" value="Levofloxacin" score="1.00" ID="285592">levofloxacin </Semaphore>on 3 January 2013, the patient experienced suspected bilateral achilleus <Semaphore x="2605291" class="Disease or Finding" value="Tendonitis" score="1.00" ID="C97141">tendonitis</Semaphore>. The patient was hospitalised. At the time of reporting, the <Semaphore x="2353201" class="Disease or Finding" value="Outcome" score="1.00" ID="C20200">outcome </Semaphore>of the event was unknown. The regulatory authority reported that the event was possibly related to <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>with <Semaphore x="780931" class="Medicine" value="Levofloxacin" score="1.00" ID="285592">levofloxacin</Semaphore>, <Semaphore x="189558" class="Medicine" value="Beclomethasone Dipropionate" score="0.93" ID="227553">beclomethasone dipropionate</Semaphore>, salbutamol sulphate, <Semaphore x="166901" class="Medicine" value="Aspirin" score="0.93" ID="212518">aspirin</Semaphore>, frusemide, <Semaphore x="1119676" class="Medicine" value="Ramipril" score="0.98" ID="258414">ramipril</Semaphore>, nitroglycerine, <Semaphore x="857793" class="Medicine" value="metFORMIN hydrochloride" score="0.98" ID="249555">metformin hydrochloride</Semaphore>, <Semaphore x="770601" class="Medicine" value="lansoprazole" score="0.98" ID="239887">lansoprazole </Semaphore>and <Semaphore x="309609" class="Medicine" value="carvedilol" score="0.98" ID="241573">carvedilol</Semaphore>.</narrativeincludeclinical>
<sendercomment>Sanofi-aventis company comment dated 09-Jan-2013: The casual role cannot be assessed in isolation as the patient is taking multiple suspect drugs.

Sanofi-Aventis company comment dated 24-Jan-13: Although the role of carvedilol,ramipril,furosemide,lansoprazole cannot be denied for the event of tendonitis however contributory role of co-suspect drugs cannot be underestimated either.</sendercomment>
</summary>
</patient>
</safetyreport>
</ichicsr></original></faers>